World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 28 November 2016
Main ID:  ISRCTN84179821
Date of registration: 14/11/2016
Prospective Registration: No
Primary sponsor: HAN University of Applied Sciences
Public title: Implementation effectiveness of supporting ICUs
Scientific title: Effectiveness of supporting intensive care units on implementing the guideline 'End-of-life care in the intensive care unit, nursing care': a cluster randomised controlled trial
Date of first enrolment: 01/10/2014
Target sample size: 1560
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN84179821
Study type:  Interventional
Study design:  Cluster randomised controlled trial (Other)  
Phase: 
Countries of recruitment
Netherlands
Contacts
Name: Lilian    Vloet
Address:  HAN University of Applied Sciences Research department Emergency and Critical Care Postbus 6960 6503 GL Nijmegen Netherlands
Telephone: +31 653981819
Email: lilian.vloet@han.nl
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Nurses:
1. Working in the ICU
2. Graduated as a ICU nurse
3. Dutch speaking
4. Experience with EOLC in the ICU

Family of deceased ICU patients:
1. Dutch speaking
2. Aged 18 years and over
3. 4-5 weeks after death of the patient
3. Contact person of the deceased patient

Exclusion criteria: Nurses:
No experience with End-of-life care.

Family:
Family of patients who were organ donors.


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Nursing guidelines
Not Applicable
Nursing guidelines
Intervention(s)
Participating ICUs are randomly allocated to two groups (manual generated randomization with random allocation concealment), without stratification of ICU size.

Both the intervention and control groups made their own implementation plan and implemented the guideline on their own ICU, with a project team.

Intervention group: ICUs are supported by a training program focusing on implementation processes and strategies and sharing experiences and best practices from other intervention sites. Training takes place over 4 days and consists of a combination of lectures and workshops which cover:
Day 1: Development of specific implementation plan and context analysis
Day 2: Context analysis and Implementation strategies
Day 3: Implementation strategies and Implementation plan
Day 4: Implementation plan and Embedding and monitoring

Control group: ICUs receive no support during the implementation and have to implement the guideline by themselves without supervision from the research group.

Follow up for all ICUs involves interviewing two ICU nurses from each participating ICU after 6 and 9 months and interviewing relatives of patients who have died 4-5 weeks previously at 9 months.
Primary Outcome(s)
Adherence to guidelines for end-of-life care is measured by a questionnaire for ICU nurses applying 25 recommendations of the guideline at baseline, and after 6 and 9 months.
Secondary Outcome(s)
Experiences of ICU nurses and family of deceased patients are measured the Quality of Death and Dying (QDD) and Consumer Quality Index (CQI-R), relatives in the ICU (LAIZ 2016) questionnaires at 9 months.
Secondary ID(s)
2013-15-16p
Source(s) of Monetary Support
Foundation Innovation Alliance, Regional Attention and Action for Knowledge circulation
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history